The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer

Enhancer RNAs (eRNAs), the transcriptional products of active enhancers, are of great significance in the initial progression of cancers. However, the biological function and bioinformatics profiles of eRNA in gastric cancer remains largely enigmatic.

• Publication year

  2022

• Venue

  Cancer Medicine

• Publication date

  2022-07-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cam4.4959PMID 35801342PMCID 9883414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer

  2022cited by this paper
• Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence

  2021cited by this paper
• Cancer neoantigens as potential targets for immunotherapy

  2021cited by this paper
• Cancer Stemness: p53 at the Wheel

  2021cited by this paper
• IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis.

  2020cited by this paper
• A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.

  2020cited by this paper
• KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.

  2020cited by this paper
• Gastric cancer mortality rates among US and foreign-born persons: United States 2005–2014

  2019cited by this paper
• ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.

  2019cited by this paper
• A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

  2019cited by this paper
• Epigenetic control of transcriptional regulation in pluripotency and early differentiation

  2019cited by this paper
• Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer

  2019cited by this paper
• Behind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers

  2019cited by this paper
• The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.

  2019cited by this paper
• Resident memory T cells, critical components in tumor immunology

  2018cited by this paper
• Integrative detection and analysis of structural variation in cancer genomes

  2018cited by this paper
• Cancer immunoediting and resistance to T cell-based immunotherapy

  2018cited by this paper
• Different Neuronal Activity Patterns Induce Different Gene Expression Programs.

  2018cited by this paper
• Morbidity and mortality according to age following gastrectomy for gastric cancer

  2018cited by this paper
• Widespread transcriptional pausing and elongation control at enhancers

  2018cited by this paper
• Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection

  2018cited by this paper
• Super-Enhancer-Driven Transcriptional Dependencies in Cancer.

  2017cited by this paper
• Chromosomal instability drives metastasis through a cytosolic DNA response

  2017cited by this paper
• Cistrome Cancer: A Web Resource for Integrative Gene Regulation Modeling in Cancer.

  2017cited by this paper
• Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution.

  2016cited by this paper
• Cistrome and Epicistrome Features Shape the Regulatory DNA Landscape.

  2016cited by this paper
• Enhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases.

  2016cited by this paper
• The selection and function of cell type-specific enhancers

  2015cited by this paper
• CRISPR Reveals a Distal Super-Enhancer Required for Sox2 Expression in Mouse Embryonic Stem Cells

  2014cited by this paper
• Master transcription factors and mediator establish super-enhancers at key cell identity genes.

  2013cited by this paper
• Super-enhancers in the control of cell identity and disease.

  2013cited by this paper
• Enhancers: five essential questions

  2013cited by this paper
• Integrative Genomics Viewer

  2011cited by this paper
• Genomic Views of Distant-Acting Enhancers

  2009cited by this paper

• Mechanisms and therapeutic strategies to reveal and overcome T-cell dysfunction in gastric cancer: translation from basic research to clinical application

  2025cites this paper
• Decoding cancer heterogeneity through super-enhancer landscapes: from subtype discovery to therapeutic opportunity

  2025cites this paper
• Integrated analysis of transcriptome and epigenome reveals ENSR00000272060 as a potential biomarker in gastric cancer.

  2024cites this paper
• Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer

  2023cites this paper
• The landscape of enhancer RNA identify prognosis‐related molecular subtypes in gastric cancer

  2022cites this paper